Mathilde Cailliez

1.3k total citations
23 papers, 681 citations indexed

About

Mathilde Cailliez is a scholar working on Nephrology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mathilde Cailliez has authored 23 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 9 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mathilde Cailliez's work include Complement system in diseases (8 papers), Renal Diseases and Glomerulopathies (7 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Mathilde Cailliez is often cited by papers focused on Complement system in diseases (8 papers), Renal Diseases and Glomerulopathies (7 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Mathilde Cailliez collaborates with scholars based in France, Serbia and Finland. Mathilde Cailliez's co-authors include Chantal Loirat, Florentine Garaix, Bruno Daniele, Michel Tsimaratos, Caroline Rousset‐Rouvière, Véronique Frémeaux‐Bacchi, Fádi Fakhouri, Véronique Baudouin, Stéphane Decramer and Yahsou Delmas and has published in prestigious journals such as The FASEB Journal, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Mathilde Cailliez

21 papers receiving 665 citations

Peers

Mathilde Cailliez
Nicolò Ghiringhelli Borsa United States
Ari M. Simckes United States
M Foulard France
J.P. Soulillou France
Julie Peltier France
Nadia Arzouk France
Caroline Rousset‐Rouvière France
Mushfequr R. Haq United Kingdom
Paola Bettinaglio Italy
Satoshi Higasa Japan
Nicolò Ghiringhelli Borsa United States
Mathilde Cailliez
Citations per year, relative to Mathilde Cailliez Mathilde Cailliez (= 1×) peers Nicolò Ghiringhelli Borsa

Countries citing papers authored by Mathilde Cailliez

Since Specialization
Citations

This map shows the geographic impact of Mathilde Cailliez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Cailliez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Cailliez more than expected).

Fields of papers citing papers by Mathilde Cailliez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Cailliez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Cailliez. The network helps show where Mathilde Cailliez may publish in the future.

Co-authorship network of co-authors of Mathilde Cailliez

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Cailliez. A scholar is included among the top collaborators of Mathilde Cailliez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Cailliez. Mathilde Cailliez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sissy, Carine El, Mathilde Cailliez, Aude Servais, et al.. (2024). Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy Phenotype. Journal of the American Society of Nephrology. 36(2). 264–273. 2 indexed citations
2.
Bertholet‐Thomas, Aurélia, Maria A. Manso-Silván, Véronique Baudouin, et al.. (2021). Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis. Pediatric Nephrology. 36(7). 1765–1774. 11 indexed citations
3.
Ovaert, Caroline, et al.. (2021). Dilatation of the aorta in children with advanced chronic kidney disease. Pediatric Nephrology. 36(7). 1825–1831. 2 indexed citations
4.
Cailliez, Mathilde, et al.. (2021). Threatening Blindness in a Child With Typical Hemolytic Uremic Syndrome. Pediatric Neurology. 122. 35–37.
5.
Bertholet‐Thomas, Aurélia, Maria A. Manso-Silván, Véronique Baudouin, et al.. (2020). Correction to: Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments. Pediatric Nephrology. 36(1). 215–215. 11 indexed citations
6.
Frémeaux‐Bacchi, Véronique, Anne‐Laure Sellier‐Leclerc, Paula Vieira‐Martins, et al.. (2019). Complement Gene Variants and Shiga Toxin–Producing Escherichia coli–Associated Hemolytic Uremic Syndrome. Clinical Journal of the American Society of Nephrology. 14(3). 364–377. 30 indexed citations
7.
Quintrec, Moglie Le, Anne‐Laure Lapeyraque, Arnaud Lionet, et al.. (2018). Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy. American Journal of Kidney Diseases. 72(1). 84–92. 89 indexed citations
8.
Paula, A. Maues de, et al.. (2018). Hepatocarcinoma and Cholestasis Associated to Germline Hemizygous Deletion of Gene HNF1B. Journal of Pediatric Gastroenterology and Nutrition. 68(5). e85–e85. 6 indexed citations
9.
Chauvet, Sophie, Moglie Le Quintrec, Florent Petitprez, et al.. (2017). C5 nephritic factors drive the biological phenotype of C3 glomerulopathies. Kidney International. 92(5). 1232–1241. 72 indexed citations
10.
Fakhouri, Fádi, Marc Fila, François Provôt, et al.. (2016). Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation. Clinical Journal of the American Society of Nephrology. 12(1). 50–59. 126 indexed citations
11.
Rousset‐Rouvière, Caroline, Mathilde Cailliez, Florentine Garaix, et al.. (2014). Rituximab fails where eculizumab restores renal function in C3nef-related DDD. Pediatric Nephrology. 29(6). 1107–1111. 50 indexed citations
12.
Cailliez, Mathilde, et al.. (2013). Diagnosis of Streptococcus pneumoniae–associated Hemolytic Uremic Syndrome. The Pediatric Infectious Disease Journal. 32(10). 1045–1049. 18 indexed citations
13.
Tellier, Stéphanie, Karine Brochard, Arnaud Garnier, et al.. (2013). Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome. Pediatric Nephrology. 28(6). 911–918. 36 indexed citations
14.
Chiavérini, C., Hee Young Kang, L. Sillard, et al.. (2011). In vivo reflectance confocal microscopy of the skin: A noninvasive means of assessing body cystine accumulation in infantile cystinosis. Journal of the American Academy of Dermatology. 68(4). e111–e116. 12 indexed citations
15.
Baudouin, Véronique, Corinne Alberti, Anne‐Laure Lapeyraque, et al.. (2011). Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial. Pediatric Nephrology. 27(3). 389–396. 44 indexed citations
16.
Zhao, Wei, Valery Élie, Véronique Baudouin, et al.. (2010). Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome. British Journal of Clinical Pharmacology. 69(4). 358–366. 35 indexed citations
17.
Garaix, Florentine, et al.. (2009). Peut-on ralentir la progression des lésions liées à la réduction néphronique ?. Archives de Pédiatrie. 16(6). 703–705.
18.
Rousset‐Rouvière, Caroline, Florentine Garaix, Mathilde Cailliez, et al.. (2009). Rein et vascularite chez l’enfant. Archives de Pédiatrie. 16(6). 529–531. 1 indexed citations
19.
Niaudet, Patrick, Marina Charbit, Chantal Loirat, et al.. (2008). Enteric-coated mycophenolate sodium in de novo pediatric renal transplant patients. Pediatric Nephrology. 24(2). 395–402. 3 indexed citations
20.
Cailliez, Mathilde, Bruno Daniele, Laurent Daniel, et al.. (2007). Le mycophénolate mofétil améliore la fonction rénale et l’imprégnation cortisonique au cours du syndrome néphrotique corticodépendant de l’enfant. Une étude de cohorte. Néphrologie & Thérapeutique. 4(1). 15–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolò Ghiringhelli Borsa Breakdown of academic impact, for papers by Ari M. Simckes Breakdown of academic impact, for papers by M Foulard Breakdown of academic impact, for papers by J.P. Soulillou Breakdown of academic impact, for papers by Julie Peltier Breakdown of academic impact, for papers by Nadia Arzouk Breakdown of academic impact, for papers by Caroline Rousset‐Rouvière Breakdown of academic impact, for papers by Mushfequr R. Haq Breakdown of academic impact, for papers by Paola Bettinaglio Breakdown of academic impact, for papers by Satoshi Higasa
Rankless by CCL
2026